Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals (Q44912219)

7 December 2017

title

Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals (English)

1 reference

7 December 2017

0 references

Staphylococcus aureus

1 reference

4

1 reference

7 December 2017

Conan MacDougall

1

1 reference

7 December 2017

J Patrick Powell

series ordinal

2

1 reference

7 December 2017

Christopher K Johnson

series ordinal

3

1 reference

7 December 2017

Ronald E Polk

series ordinal

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

28 June 2005

1 reference

Clinical Infectious Diseases

7 December 2017

published in

1 reference

7 December 2017

volume

41

1 reference

7 December 2017

issue

4

1 reference

7 December 2017

page(s)

435-440

1 reference

The fluoroquinolone antibacterials: past, present and future perspectives

7 December 2017

cites work

1 reference

Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000

21 January 2018

1 reference

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

21 January 2018

1 reference

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study

21 January 2018

1 reference

Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials

21 January 2018

1 reference

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients

21 January 2018

1 reference

Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure

21 January 2018

1 reference

Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin

21 January 2018

1 reference

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

21 January 2018

1 reference

Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms

21 January 2018

1 reference

Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.

21 January 2018

1 reference

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.

21 January 2018

1 reference

The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported

21 January 2018

1 reference

Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections

21 January 2018

1 reference

Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection

21 January 2018

1 reference

Clinical and molecular epidemiology of quinolone-resistant Escherichia coli isolated from urinary tract infection

21 January 2018

1 reference

Influence of population density on antibiotic resistance

21 January 2018

1 reference

Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens

21 January 2018

1 reference

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains

21 January 2018

1 reference

Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998.

21 January 2018

1 reference

Origins of community strains of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin

21 January 2018

1 reference

Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States

21 January 2018

1 reference

Effect of Duplicate Isolates of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus on Antibiogram Data

21 January 2018

1 reference

Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/432056

1 reference

7 December 2017

1 reference